Background: The prevalence of both obesity & diabetes are increasing all over the world & more in women. They have a negative impact not only on morbidity & mortality but also on quality of life. Objectives: To assess the HRQoL with a specific comparison between obese & normal weight among women with Type 2 Diabetes Mellitus. Subjects and Methods: A cross sectional study was conducted among 618 diabetic women aged 18 to 45 years. Data collection was done by interview & SF36 questionnaire. A comparison for Physical Component Summary & Mental Component Summary scores were done on the base of their Body Mass Index. Results: There was a significant difference score between obese & normal patients in PCS (p=0.001) & in MCS (p=0.009). The normal weight patients had significantly higher PCS mean (±SD), in strata of ; age (≤35,>35)=78.43(±8.80), 65.02(±17.9) /socioeconomic status (poor, fair) =69.96(±20.72), 67.50(±15.71) /marital status (single, married, divorced or widowed)=72.50(±14.81), 67.68(±17.44), 71.09(±16.79) /number of children (≤ 2 / >2 ) =68.66(±12.91), 69.64(±20.82) /smoking (smoker , nonsmoker) =72.50(±8.55), 68.44(±17.34) / duration of DM (5-10 year, >10 year) =67.68(±16.46), 70.27(±17.18)/complications of DM (one complication , > one complications) =71.12(±15.56), 77.91(±8.98)/treatment type (OHM, injection, both) =64.86(±18.87), 73.67(±14.49), 60.00 (±10.31)& regularity of visit (poor,fair,good) =66.25(±9.78), 60.31(±19.73), 72.63(±14.00). Also the same thing in MCS mean (±SD), in strata of; (SES) (poor) =72.11(±18.82), number of children (>2) =69.20(±19.66), smoking (smoker) =82.25(±11.50), duration of DM (>10 year) =67.55(±16.3), complications of DM (> one complications) =65.81(±10.17), & regularity of visit (poor) =59.86(±18.46). Conclusions: Obese patients have a lower score as compared with normal weight patients in PCS & MCS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.